k豆钱包

        Product logins

        Find logins to all Clarivate products below.


        Keval Vasavada

        Director, Consulting

        Keval Vasavada comes with a right mix of consulting as well as industry experience in pharmaceutical and life sciences.

        He holds over 13 years of experience spanning corporate strategy, operations, new process set-up, new product launches, corporate finance, fund raising and commercial deals. Prior to Clarivate, Keval worked with Cipla Pharmaceuticals and IQVIA Consulting.

        He has worked on developing disruptive, competitive and sustainable business model for biosimilar business in his previous assignment. He understands the nuances of biopharma manufacturing and has spearheaded commercial discussions with top suppliers of biopharma equipment in the past.

        During his consulting stint, he has led projects involving asset portfolio strategy, market entry strategy, commercial due diligence, opportunity assessment for novel therapies in Japan, Asia-Pacific, US, and Europe. He has a rich exposure of working across a breadth of therapeutic areas involving oncology, immunology, neurology, respiratory, rare diseases, and metabolic disorders.

        Keval has completed his MBA from the prestigious Indian Institute of Management, Lucknow (India) and did his B.Tech. in Dairy Technology from Dairy Science College, Anand (Gujarat, India).

        Related resources

        Blog February 2, 2026
        医疗保健支付方回报的是什么:依从性与结果
        医疗保险 定价 案例研究 生物类似药 真实世界数据 美国市场
        Blog January 26, 2026
        实现便利性的价值:药企的支付方参与策略
        医疗保险 定价 案例研究 真实世界数据 美国市场
        Blog December 18, 2025
        深入了解 SMA 的流行病学
        流行病学 真实世界数据
        Blog December 8, 2025
        使用流行病学数据预测目标市场:k豆钱包的方法论
        AI/机器学习 市场准入 流行病学 真实世界数据